Home › Inflammatory Bowel Disease › Georgia
Inflammatory Bowel Disease clinical trials in Georgia
9 studies for Inflammatory Bowel Disease are looking for participants at sites in Georgia.
Cities in Georgia
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Emory University, Atlanta
- Children's Center for Digestive Health Care, Atlanta
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Sep 25, 2026 · NCT05923073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Emory University School of Medicine, Atlanta
- Children's Center for Digestive Health Care, LLC, Atlanta
RecruitingPhase 3
Ages 2 to 19 · All sexes · Updated Sep 22, 2026 · NCT04844606A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- Atlanta Gastroenterology Specialists, PC, Atlanta
- Atlanta Gastroenterology Associates (Part of United Digestive), Atlanta
RecruitingPhase 2
Ages 18 to 85 · All sexes · Updated Sep 22, 2026 · NCT06226883Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
- Gastroenterology Consultants, P.C., Roswell
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 21, 2026 · NCT07513181A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Emory University, Atlanta
- Children's Center for Digestive Health Care, LLC, Atlanta
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Aug 24, 2026 · NCT05509777Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Emory University, Atlanta
RecruitingPhase 4
Ages 6 to 17 · All sexes · Updated May 27, 2026 · NCT05781152Heart Rate Variability and Inflammatory Bowel Disease
- Atlanta Metropolitan Area, Atlanta
- Children's Healthcare of Atlanta, Atlanta
- Center for Advanced Pediatrics, Atlanta
Recruiting
Ages 13 to 18 · All sexes · Updated Apr 1, 2026 · NCT06537258A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Atlanta
- Mirador Therapeutics Selected Site, Snellville
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Mar 12, 2026 · NCT07113522Testing the Impact of Measurement-Based Care on Quality of Life and Disease Management Among Veterans With Inflammatory Bowel Disease
- Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur
Recruiting
Ages 18 and older · All sexes · Updated Mar 11, 2026 · NCT07210580From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.